Trials / Completed
CompletedNCT01395862
Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,001 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to detect adverse drug reactions for long-term use (particularly clinically significant adverse drug reactions) occurring in clinical settings, to examine factors likely to affect the safety and efficacy in the Japanese asthma patients who are treated with fluticasone propionate/salmeterol xinafoate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salmeterol and Fluticasone |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2011-07-18
- Last updated
- 2013-08-21
Source: ClinicalTrials.gov record NCT01395862. Inclusion in this directory is not an endorsement.